AGP Picks
View all

Michigan Technology Journal
Provided by AGP

Michigan Technology Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Michigan Technology Journal.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on April 2, 2026

Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds
Apr. 2, 2026

Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds

Indeterminate GlobeNewswire
DIVEVOLK Partners with 2026 Russia’s Underwater Photo Awards as Founding Sponsor and Exclusive Mobile Photography Category Backer
Apr. 2, 2026

DIVEVOLK Partners with 2026 Russia’s Underwater Photo Awards as Founding Sponsor and Exclusive Mobile Photography Category Backer

Indeterminate GlobeNewswire
Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies
Apr. 2, 2026

Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies

Indeterminate GlobeNewswire
Myseum Brings Free Private Social Network to 10,000 Weddings Where Every Guest Becomes the Photographer
Apr. 2, 2026

Myseum Brings Free Private Social Network to 10,000 Weddings Where Every Guest Becomes the Photographer

Indeterminate GlobeNewswire
Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market
Apr. 2, 2026

Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market

Indeterminate GlobeNewswire
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York
Apr. 2, 2026

Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York

Indeterminate GlobeNewswire
Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update
Apr. 2, 2026

Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update

Indeterminate GlobeNewswire
Oncotelic Therapeutics Announces Strategic Partnership with TechForce Robotics to Commercialize PDAOAI-Enhanced GMP Robotics Platform
Apr. 2, 2026

Oncotelic Therapeutics Announces Strategic Partnership with TechForce Robotics to Commercialize PDAOAI-Enhanced GMP Robotics Platform

Indeterminate GlobeNewswire
ZenaTech Initiates New Operations in Ukraine to Accelerate Production of Counter-UAS Interceptor Systems
Apr. 2, 2026

ZenaTech Initiates New Operations in Ukraine to Accelerate Production of Counter-UAS Interceptor Systems

Indeterminate GlobeNewswire
Cycurion Goes on Offense: Initiates Legal Action and Seeks Millions in Damages Against ACCESS Newswire and Those Responsible for Disseminating the Unauthorized and Fraudulent Release
Apr. 2, 2026

Cycurion Goes on Offense: Initiates Legal Action and Seeks Millions in Damages Against ACCESS Newswire and Those Responsible for Disseminating the Unauthorized and Fraudulent Release

Indeterminate GlobeNewswire
Dan Herbatschek Sees $1 Trillion AI Spend Crisis as Enterprise AI Costs Surge
Apr. 2, 2026

Dan Herbatschek Sees $1 Trillion AI Spend Crisis as Enterprise AI Costs Surge

Indeterminate GlobeNewswire
Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company
Apr. 2, 2026

Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company

Indeterminate GlobeNewswire
SPARC AI Releases Latest Investor Presentation
Apr. 2, 2026

SPARC AI Releases Latest Investor Presentation

Indeterminate GlobeNewswire
Satellite Broadband Reaches an Inflection Point as Global Subscriptions Set to Exceed 43 Million by 2035
Apr. 2, 2026

Satellite Broadband Reaches an Inflection Point as Global Subscriptions Set to Exceed 43 Million by 2035

Indeterminate GlobeNewswire
Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium
Apr. 2, 2026

Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium

Indeterminate GlobeNewswire
Roper Technologies schedules first quarter 2026 financial results conference call
Apr. 2, 2026

Roper Technologies schedules first quarter 2026 financial results conference call

Indeterminate GlobeNewswire
Wagner Acquires 9 Million Rezolve Ai Shares in Strong Vote of Confidence
Apr. 2, 2026

Wagner Acquires 9 Million Rezolve Ai Shares in Strong Vote of Confidence

Indeterminate GlobeNewswire
Calidi Biotherapeutics to Present New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026
Apr. 2, 2026

Calidi Biotherapeutics to Present New Data on Its Lead Asset CLD-401 at the AACR Annual Meeting in April 2026

Indeterminate GlobeNewswire
Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive
Apr. 2, 2026

Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive

Indeterminate GlobeNewswire
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr. 2, 2026

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

Michigan Technology Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.